Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges.

ABSTRACT: Cancer is one of the major leading causes of mortality in the world. The implication of nanotherapeutics in cancer has garnered splendid attention owing to their capability to efficiently address various difficulties associated with conventional drug delivery systems such as non-specific biodistribution, poor efficacy, and the possibility of occurrence of multi-drug resistance. Amongst a plethora of nanocarriers for drugs, this review emphasized lipidic nanocarrier systems for delivering anticancer therapeutics because of their biocompatibility, safety, high drug loading and capability to simultaneously carrying imaging agent and ligands as well. Furthermore, to date, the lack of interaction between diagnosis and treatment has hampered the efforts of the nanotherapeutic approach alone to d

SUBMITTER: Bukhari SI 

PROVIDER: S-EPMC8226834 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature